Long-term methadone intake and genotoxicity in addicted patients

Area of Science:

• Pharmacology
• Genetics
• Toxicology

Background:

• Pharmaceuticals, especially those with long-term use or misuse potential, can induce mutations.
• Methadone is an opioid agonist used for pain management and opioid addiction treatment.

Purpose of the Study:

• To evaluate the mutagenic effects of methadone in addicted patients.
• To assess genome instability using the comet assay technique.

Main Methods:

• A study involving 90 subjects divided into a methadone-treated group, a healthy control group, and a positive control group.
• Blood samples were collected, lymphocytes isolated, and analyzed using the single-cell gel electrophoresis (comet assay) technique.
• Mutagenicity was assessed by analyzing comet patterns under fluorescence microscopy.

Main Results:

• Addicted patients undergoing methadone treatment exhibited a significantly higher mutagenicity index compared to healthy volunteers.
• The observed mutagenicity in the methadone group was lower than that of the positive control group.

Conclusions:

• The study demonstrates genome instability in patients undergoing methadone treatment.
• Further long-term studies are required to reconcile conflicting findings and fully understand the consequences of methadone use on genetic integrity.